News
Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $55 from $60 and keeps an Overweight rating on the shares. The firm is ...
Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customers KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE ...
In wenigen Tagen steht die 18. Meisterschaftsrunde in der Tirol Liga auf dem Programm. Ligaportal.at liefert an jedem Spieltag einen interessanten Vergleich der jeweils duellierenden Teams mit ...
Google Cloud’s Vertex AI, a machine learning (ML) platform, is receiving significant updates. Vertex AI is a tool for enterprise AI development. Unlike consumer-facing AI like Gemini or ChatGPT ...
Google is adding a new open source framework for building agents to its AI and machine learning platform Vertex AI, along with other updates to help deploy and maintain these agents. It unveiled ...
Shares of Vertex have rallied, even amid the broader stock market sell-off. The company is diversifying beyond its dominance in cystic fibrosis treatments. Several catalysts in 2025 support a ...
Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...
At the 2025 Napa Valley Biotech Forum, JPMorgan analyst Jessica Fye walked away with a bullish tone after conversations with Vertex CEO Reshma Kewalramani and Senior Vice President of Investor ...
Christoph Mayr, Obmann Lukas Haberl, Hannes Schrattenthaler, Michael Kwasnitzka, Johann Laiminger, Georg Kwasnitzka, Bianca Egger und Bgm Herbert Rieder (v.l.) Foto: BMK Kirchbichl hochgeladen von ...
Vertex Pharmaceuticals announced Friday afternoon that it won’t move forward with its type 1 diabetes cell therapy that’s delivered in a … ...
Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results